Literature DB >> 8909250

Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.

U Müller-Ladner1, J Kriegsmann, B N Franklin, S Matsumoto, T Geiler, R E Gay, S Gay.   

Abstract

Rheumatoid arthritis (RA) has been thought to be largely a T-cell-mediated disease. To evaluate the role of T-cell-independent pathways in RA, we examined the interaction between isolated RA synovial fibroblasts and normal human cartilage engrafted into SCID mice in the absence of T cells and other human cells. The expression of cartilage-de grading enzymes and adhesion molecules was examined by immunohistochemistry and in situ hybridization techniques. The RA synovial fibroblasts invaded the cartilage and kept their transformed appearing cellular shape. They expressed VCAM-1 and produced the cathepsins L and B at the site of invasion. We conclude that RA synovial fibroblasts maintain their invasive and destructive behavior over longer periods of time in the absence of human T cells, indicating that T-cell-independent pathways play a significant role in rheumatoid joint destruction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909250      PMCID: PMC1865262     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Augmented excretion of procathepsin L of a fos-transferred highly metastatic rat cell line.

Authors:  S Taniguchi; Y Nishimura; T Takahashi; T Baba; K Kato
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

Review 2.  Mechanisms of matrix degradation in rheumatoid arthritis.

Authors:  S M Krane; W Conca; M L Stephenson; E P Amento; M B Goldring
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.

Authors:  Q Nguyen; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  Characterization and isolation of poly- and monoclonal antibodies against collagen for use in immunohistochemistry.

Authors:  S Gay; J D Fine
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

Authors:  M J Elices; L Osborn; Y Takada; C Crouse; S Luhowskyj; M E Hemler; R R Lobb
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

6.  Histomorphological basis of articular cartilage destruction in rheumatoid arthritis.

Authors:  H G Fassbender
Journal:  Coll Relat Res       Date:  1983-03

7.  Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry.

Authors:  S S McCachren; B F Haynes; J E Niedel
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

8.  Monoclonal antibodies to human prolyl 4-hydroxylase.

Authors:  M Höyhtyä; R Myllylä; J Piuva; K I Kivirikko; K Tryggvason
Journal:  Eur J Biochem       Date:  1984-06-15

9.  Collagenase at sites of cartilage erosion in the rheumatoid joint.

Authors:  D E Woolley; M J Crossley; J M Evanson
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

Review 10.  Oncogenes in rheumatoid arthritis.

Authors:  U Müller-Ladner; J Kriegsmann; R E Gay; S Gay
Journal:  Rheum Dis Clin North Am       Date:  1995-08       Impact factor: 2.670

View more
  210 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 2.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

3.  Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

Authors:  R A Carter; I K Campbell; K L O'Donnel; I P Wicks
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 4.  MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?

Authors:  U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

6.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

7.  Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor.

Authors:  H Kameda; H Ishigami; M Suzuki; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 8.  Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways.

Authors:  C Ospelt; D Kyburz; M Pierer; R Seibl; M Kurowska; O Distler; M Neidhart; U Muller-Ladner; T Pap; R E Gay; S Gay
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 9.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

10.  Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells.

Authors:  Johnson D S Chang; Hou-Shan Lu; Ye-Fun Chang; David Wang
Journal:  Rheumatol Int       Date:  2004-11-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.